Applikon to distribute Niro homogenisers
Applikon Biotech has entered into an agreement with Niro Soavi for
the distribution of lab-scale homogenisers to the fermentation
market in North America.
EU states taken to ECoJ over biotech
European Commission refers eight EU member states to the European
Court of Justice over their alleged failure to implement legal
protection of biotech inventions.
IT consultancy branches into life sciences
CTG, a specialist in validation and verification information
technology and good automated manufacturing practices, has set up a
consultancy to serve companies in the life sciences sector.
Denmark booms on back of US exports
Danish pharmaceutical companies increased their sales to overseas
countries by 20 per cent in the first four months of this year
compared with the same period of 2002, according to Invest In
Merck cuts activities in France
Merck KGaA has trimmed down its operations in France with the
closure of a site at Lacassagne focusing on preclinical R&D and
Integra culture vessel boosts MAb production
A new range of cell culture vessels developed by Switzerland's
Integra Biosciences promises to increase production yields in
laboratories making monoclonal antibodies and recombinant proteins.
Lock offers key to Part 11 compliance
Lock has developed a software package for its metal detection
systems that will make it easier for drugmakers to comply with Part
Lonza expands into discovery with Vaccinex deal
A deal with Vaccinex has taken Lonza Biologics beyond its primary
focus of mammalian cell culture-based manufacturing and into the
area of antibody drug discovery.
Joint venture takes Profile towards US presence
A joint venture between UK inhaler specialist Profile and generics
company Breath opens up a new market valued at $1 billion
€2bn credit facility for Degussa
Germany's third largest chemical company has raised € 2 bn of
credit lines by means of a syndicated facility with a group of
leading international banks.
Chiron collars PowderJect
Chiron's has completed its acquisition of UK vaccine and drug
delivery specialist PowderJect, making it the second-largest
manufacturer of flu vaccines worldwide.
DSM-Gist signs Chinese deal
DSM Gist has entered into an agreement with China's Guangzhou
Baiyunshan General Pharma for the supply and development of
BASF outlines plan for a greener future
BASF has put forwards environmental and safety standards that will
see it comfortably meet and exceed the pledges for greenhouse gas
emissions laid down by the Kyoto Protocol. The firm stresses the
need for a voluntary system of control,...
EU and Japan seek to align GMP
The European Union and Japan have agreed that there is still a lot
of work to be done before a system of mutual recognition of Good
Manufacturing Practice standards can be put in place.
Massachusetts to get biotech boost
Four Massachusetts-based companies have hatched a scheme to develop
a large-scale biotechnology manufacturing facility in the state.